203 related articles for article (PubMed ID: 37678326)
1. Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell Transplantation.
Hoogland AI; Gonzalez BD; Park JY; Small BJ; Sutton SK; Pidala JA; Smith KS; Bower JE; Jacobsen PB; Jim HSL
Psychosom Med; 2023 Nov-Dec 01; 85(9):813-819. PubMed ID: 37678326
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
[TBL] [Abstract][Full Text] [Related]
4. Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation.
Rentscher KE; Carroll JE; Juckett MB; Coe CL; Broman AT; Rathouz PJ; Hematti P; Costanzo ES
J Natl Cancer Inst; 2021 Oct; 113(10):1405-1414. PubMed ID: 33693799
[TBL] [Abstract][Full Text] [Related]
5. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A
Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725
[TBL] [Abstract][Full Text] [Related]
6. Correlates of anxiety and depression symptoms among patients and their family caregivers prior to allogeneic hematopoietic cell transplant for hematological malignancies.
Posluszny DM; Bovbjerg DH; Syrjala KL; Agha M; Dew MA
Support Care Cancer; 2019 Feb; 27(2):591-600. PubMed ID: 30022348
[TBL] [Abstract][Full Text] [Related]
7. Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?
Sucheston-Campbell LE; Clay A; McCarthy PL; Zhu Q; Preus L; Pasquini M; Onel K; Hahn T
Curr Hematol Malig Rep; 2015 Mar; 10(1):45-58. PubMed ID: 25700678
[TBL] [Abstract][Full Text] [Related]
8. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
9. New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT).
Arslan S; Al Malki MM
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):74-82. PubMed ID: 36485163
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.
Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.
El-Jawahri A; Fishman SR; Vanderklish J; Dizon DS; Pensak N; Traeger L; Greer JA; Park ER; Markovitz N; Waldman L; Hunnewell C; Saylor M; Driscoll J; Li Z; Spitzer TR; McAfee S; Chen YB; Temel JS
Cancer; 2018 Jun; 124(11):2438-2446. PubMed ID: 29537491
[TBL] [Abstract][Full Text] [Related]
12. Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Chang EK; Chanson D; Teh JB; Iukuridze A; Peng K; Forman SJ; Nakamura R; Wong FL; Cai L; Armenian SH
J Clin Oncol; 2021 Mar; 39(8):902-910. PubMed ID: 33417479
[TBL] [Abstract][Full Text] [Related]
13. Association Between Baseline Patient-Reported Outcomes and Complications of Hematopoietic Stem Cell Transplantation.
Johnson PC; Bhatt S; Reynolds MJ; Dhawale TM; Ufere N; Jagielo AD; Lavoie MW; Topping CEW; Clay MA; Rice J; Yi A; DeFilipp Z; Chen YB; El-Jawahri A
Transplant Cell Ther; 2021 Jun; 27(6):496.e1-496.e5. PubMed ID: 33789836
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation.
Jim HS; Sutton SK; Jacobsen PB; Martin PJ; Flowers ME; Lee SJ
Cancer; 2016 Apr; 122(8):1290-7. PubMed ID: 26814442
[TBL] [Abstract][Full Text] [Related]
15. Post-Traumatic Stress Symptoms in Hematopoietic Stem Cell Transplant Recipients.
Fenech AL; Van Benschoten O; Jagielo AD; Ufere NN; Topping CEW; Clay M; Jones BT; Traeger L; Temel JS; El-Jawahri A
Transplant Cell Ther; 2021 Apr; 27(4):341.e1-341.e6. PubMed ID: 33836886
[TBL] [Abstract][Full Text] [Related]
16. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation.
Hoodin F; LaLonde L; Errickson J; Votruba K; Kentor R; Gatza E; Reddy P; Choi SW
Biol Blood Marrow Transplant; 2019 Feb; 25(2):343-353. PubMed ID: 30244099
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
Fingrut W; Law A; Lam W; Michelis FV; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
Ann Hematol; 2021 Mar; 100(3):789-798. PubMed ID: 33415423
[TBL] [Abstract][Full Text] [Related]
20. Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study.
Munshi L; Darmon M; Soares M; Pickkers P; Bauer P; Meert AP; Martin-Loeches I; Staudinger T; Pene F; Antonelli M; Barratt-Due A; Demoule A; Metaxa V; Lemiale V; Taccone F; Mokart D; Azoulay E; Mehta S;
Transplant Cell Ther; 2021 Jan; 27(1):78.e1-78.e6. PubMed ID: 33011289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
